Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

VIRVir Biotechnology, Inc.

Nasdaq · CIK 0001706431
Filer categoryLarge accelerated filer
Entity typeoperating
SIC2836 Biological Products, (No Diagnostic Substances)
FY end1231
XBRL facts311

Identity from submissions API

NameVir Biotechnology, Inc.
CIK0001706431
TickersVIR
ExchangesNasdaq
Entity typeoperating
CategoryLarge accelerated filer
SIC2836 Biological Products, (No Diagnostic Substances)
EIN812730369
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone415-906-4324
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • None listed.
Business address
1800 OWENS STREET
SUITE 900
SAN FRANCISCO
CA
94158
CA
Mailing address
1800 OWENS STREET
SUITE 900
SAN FRANCISCO
CA
94158
CA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

811 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-16 4 FORM 4 0001628280-26-074056 7316
2026-11-16 4 FORM 4 0001628280-26-074055 5113
2026-11-16 424B5 424B5 0001193125-26-462355 333-299995 261556012 33 191215 1 1
2026-11-16 8-K 8-K 1.01,8.01,9.01 0001193125-26-461412 001-39083 261555001 34 482287 1 1
2026-11-16 424B5 424B5 0001193125-26-461407 333-299995 261554988 33 517657
2026-11-12 424B5 424B5 0001193125-26-458462 333-299995 261547227 33 519568
2026-11-12 S-3ASR S-3ASR 0001193125-26-458278 333-299995 261546684 33 1263763 1 1
2026-11-10 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000093751-26-000742 005-91177 261538392 34 8093
2026-11-09 8-K 8-K 7.01,8.01,9.01 0001628280-26-071908 001-39083 261533997 34 197437 1 1
2026-11-06 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001012975-26-001020 005-91177 261533348 34 22670
2026-11-04 10-Q 10-Q 0001628280-26-070273 001-39083 261523710 34 6657643 1 1
2026-11-04 8-K 8-K 2.02,9.01 0001628280-26-070148 001-39083 261522285 34 422966 1 1
2026-11-04 4 FORM 4 0001628280-26-070025 6878
2026-11-03 144 xsl144X01/primary_doc.xml 0001959173-26-007669 001-39083 261514892 33 5147
2026-11-02 144 xsl144X01/primary_doc.xml 0001959173-26-007634 001-39083 261511984 33 4544
2026-10-28 4 FORM 4 0001628280-26-067824 11151
2026-10-28 3 FORM 3 0001628280-26-067822 270974
2026-10-28 8-K 8-K 5.02 0001628280-26-067742 001-39083 261492576 34 174701 1 1
2026-10-27 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0002012383-26-003861 005-91177 261491722 34 11170
2026-10-14 8-K 8-K 3.02,8.01,9.01 0001628280-26-065826 001-39083 261458371 34 244098 1 1
2026-10-08 8-K 8-K 8.01,9.01 0001628280-26-065408 001-39083 261448390 34 242376 1 1
2026-10-06 3 FORM 3 0001628280-26-065222 267416
2026-10-01 8-K 8-K 5.02,7.01,9.01 0001628280-26-064117 001-39083 261429032 34 231829 1 1
2026-09-17 144 xsl144X01/primary_doc.xml 0001959173-26-007020 001-39083 261385563 33 9052
2026-09-09 144 xsl144X01/primary_doc.xml 0001959173-26-006814 001-39083 261367157 33 6281
2026-08-25 144 xsl144X01/primary_doc.xml 0001959173-26-006425 001-39083 261313369 33 5644
2026-08-24 144 xsl144X01/primary_doc.xml 0001959173-26-006413 001-39083 261311542 33 5003
2026-08-21 144 xsl144X01/primary_doc.xml 0001959173-26-006329 001-39083 261304372 33 4362
2026-08-12 4 FORM 4 0001628280-26-056108 7155
2026-08-07 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000093751-26-000556 005-91177 261252417 34 8122
2026-08-05 10-Q 10-Q 0001628280-26-053549 001-39083 261244898 34 6626027 1 1
2026-08-05 8-K 8-K 2.02,9.01 0001628280-26-053351 001-39083 261243554 34 434374 1 1
2026-07-31 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0002100121-26-000992 005-91177 261226740 34 7448
2026-07-24 8-K 8-K 5.02 0001628280-26-049499 001-39083 261198574 34 174942 1 1
2026-06-29 144 xsl144X01/primary_doc.xml 0001959173-26-004947 001-39083 261135184 33 4317
2026-06-10 4 FORM 4 0001628280-26-042326 11284
2026-06-10 3 FORM 3 0001628280-26-042325 267948
2026-06-10 8-K 8-K 5.02 0001628280-26-042237 001-39083 261080044 34 174667 1 1
2026-06-02 4 FORM 4 0001628280-26-039943 4884
2026-06-02 4 FORM 4 0001628280-26-039938 5166
2026-06-01 144 xsl144X01/primary_doc.xml 0001959173-26-004199 001-39083 261049911 33 5097
2026-06-01 144 xsl144X01/primary_doc.xml 0001959173-26-004187 001-39083 261049036 33 4488
2026-05-28 4 FORM 4 0001628280-26-038966 8067
2026-05-28 4 FORM 4 0001628280-26-038965 7156
2026-05-28 4 FORM 4 0001628280-26-038964 8690
2026-05-28 4 FORM 4 0001628280-26-038963 7107
2026-05-28 4 FORM 4 0001628280-26-038962 7133
2026-05-28 4 FORM 4 0001628280-26-038961 8023
2026-05-28 8-K 8-K 5.02,5.07 0001628280-26-038630 001-39083 261028995 34 186360 1 1
2026-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001493152-26-024001 005-91177 26990518 34 10710
2026-05-07 10-Q 10-Q 0001628280-26-031471 001-39083 26949898 34 7503099 1 1
2026-05-06 8-K 8-K 2.02,9.01 0001628280-26-031273 001-39083 26948486 34 423387 1 1
2026-05-04 4 FORM 4 0001628280-26-029640 5381
2026-04-30 4 FORM 4 0001628280-26-029041 6572
2026-04-30 144 xsl144X01/primary_doc.xml 0001959173-26-003135 001-39083 26920752 33 6786
2026-04-29 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0002100121-26-000797 005-91177 26915360 34 7380
2026-04-16 ARS ARS 0001140361-26-015121 001-39083 26867532 34 9499621
2026-04-16 DEFA14A DEFA14A 0001628280-26-025380 001-39083 26865815 34 1239116
2026-04-16 DEF 14A DEF 14A 0001628280-26-025379 001-39083 26865805 34 4302158 1 1
2026-04-10 8-K 8-K 5.02 0001193125-26-151209 001-39083 26854746 34 134121 1 1
2026-04-07 4 FORM 4 0001628280-26-024098 5945
2026-04-06 144 xsl144X01/primary_doc.xml 0001959173-26-002789 001-39083 26840872 33 5845
2026-04-02 4 FORM 4 0001628280-26-022971 5379
2026-03-27 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000102909-26-002579 005-91177 26805157 34 7201
2026-03-24 4 FORM 4 0001628280-26-020823 4954
2026-03-23 4 FORM 4 0001628280-26-020480 6583
2026-03-23 144 xsl144X01/primary_doc.xml 0001959173-26-002551 001-39083 26780274 33 7457
2026-03-04 8-K 8-K 5.02 0001193125-26-091447 001-39083 26721059 34 136135 1 1
2026-03-03 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001012975-26-000222 005-91177 26715968 34 19150
2026-03-03 4 FORM 4 0001628280-26-013630 7153
2026-03-02 144 xsl144X01/primary_doc.xml 0001950047-26-001998 001-39083 26708345 33 6959
2026-03-02 8-K 8-K 8.01 0001193125-26-084367 001-39083 26703718 34 135517 1 1
2026-02-26 8-K 8-K 1.01,9.01 0001193125-26-077416 001-39083 26690589 34 442642 1 1
2026-02-26 424B5 424B5 0001193125-26-077336 333-275314 26690555 33 766717 1 1
2026-02-26 4 FORM 4 0001628280-26-012397 10154
2026-02-26 4 FORM 4 0001628280-26-012396 4949
2026-02-26 4 FORM 4 0001628280-26-012395 4944
2026-02-26 4 FORM 4 0001628280-26-012394 6498
2026-02-26 4 FORM 4 0001628280-26-012393 6528
2026-02-26 4 FORM 4 0001628280-26-012390 5816
2026-02-25 144 xsl144X01/primary_doc.xml 0001493152-26-008097 001-39083 26681299 33 20205
2026-02-25 144 xsl144X01/primary_doc.xml 0001959173-26-001469 001-39083 26675319 33 6335
2026-02-25 144 xsl144X01/primary_doc.xml 0001959173-26-001456 001-39083 26674697 33 5721
2026-02-24 4 FORM 4 0001628280-26-011331 8714
2026-02-24 4 FORM 4 0001628280-26-011330 8912
2026-02-24 4 FORM 4 0001628280-26-011329 8673
2026-02-24 4 FORM 4 0001628280-26-011328 8921
2026-02-24 4 FORM 4 0001628280-26-011327 9567
2026-02-24 144 xsl144X01/primary_doc.xml 0001959173-26-001450 001-39083 26672972 33 5132
2026-02-24 144 xsl144X01/primary_doc.xml 0001959173-26-001446 001-39083 26672838 33 5212
2026-02-24 144 xsl144X01/primary_doc.xml 0001959173-26-001442 001-39083 26672668 33 5153
2026-02-24 144 xsl144X01/primary_doc.xml 0001959173-26-001441 001-39083 26672616 33 5794
2026-02-24 144 xsl144X01/primary_doc.xml 0001959173-26-001438 001-39083 26672435 33 5188
2026-02-24 144 xsl144X01/primary_doc.xml 0001950047-26-001736 001-39083 26672249 33 6971
2026-02-24 424B5 424B5 0001193125-26-067212 333-275314 26672193 33 646247
2026-02-23 S-8 S-8 0001628280-26-010757 333-293665 26666634 33 308860 1 1
2026-02-23 10-K 10-K 0001628280-26-010749 001-39083 26666585 34 29760669 1 1
2026-02-23 8-K 8-K 1.01,2.02,3.02,8.01,9.01 0001628280-26-010740 001-39083 26666472 34 575400 1 1
2026-02-23 144 xsl144X01/primary_doc.xml 0001959173-26-001373 001-39083 26666071 33 4515
2026-02-23 144 xsl144X01/primary_doc.xml 0001959173-26-001364 001-39083 26665802 33 4501
2026-02-23 144 xsl144X01/primary_doc.xml 0001959173-26-001361 001-39083 26665781 33 4574
2026-02-23 144 xsl144X01/primary_doc.xml 0001959173-26-001354 001-39083 26665536 33 4546
2026-02-23 144 xsl144X01/primary_doc.xml 0001959173-26-001351 001-39083 26665422 33 5162
2026-02-18 4 FORM 4 0001628280-26-008984 5206
2026-02-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001493152-26-007174 005-91177 26643212 34 10606
2026-02-13 144 xsl144X01/primary_doc.xml 0001959173-26-000988 001-39083 26632118 33 4529
2026-02-03 4 FORM 4 0001628280-26-004866 5242
2026-01-14 144 xsl144X01/primary_doc.xml 0001493152-26-002305 001-39083 26534533 33 17608
2026-01-12 8-K 8-K 2.02,7.01,9.01 0001628280-26-001768 001-39083 26524762 34 4912456 1 1
2026-01-05 4 FORM 4 0001628280-26-000320 5242
2026-01-02 144 xsl144X01/primary_doc.xml 0001950047-26-000060 001-39083 26502762 33 6235
2025-12-16 8-K 8-K 1.01,8.01,9.01 0001628280-25-057394 001-39083 251575660 34 293299 1 1
2025-12-03 4 4 0001493152-25-025970 10074
2025-12-02 4 FORM 4 0001628280-25-054884 5243
2025-12-01 4 xslF345X05/ownership.xml 0001493152-25-025571 12252
2025-11-26 4 4 0001493152-25-025161 12265
2025-11-25 144 xsl144X01/primary_doc.xml 0001493152-25-025052 001-39083 251523561 33 15702
2025-11-18 4 FORM 4 0001628280-25-052841 5049
2025-11-17 144 xsl144X01/primary_doc.xml 0001959173-25-007063 001-39083 251490820 33 4516
2025-11-07 4 FORM 4 0001628280-25-050592 4805
2025-11-05 10-Q 10-Q 0001628280-25-049694 001-39083 251455145 34 6089668 1 1
2025-11-05 8-K 8-K 2.02,9.01 0001628280-25-049561 001-39083 251454106 34 417999 1 1
2025-11-05 144 xsl144X01/primary_doc.xml 0001959173-25-006744 001-39083 251452129 33 5146
2025-11-04 4 FORM 4 0001628280-25-049159 5037
2025-11-04 4 FORM 4 0001628280-25-048624 5243
2025-11-03 144 xsl144X01/primary_doc.xml 0001959173-25-006682 001-39083 251443774 33 4547
2025-10-30 4 xslF345X05/ownership.xml 0001493152-25-020240 11737
2025-10-28 4 xslF345X05/ownership.xml 0001493152-25-019892 12250
2025-10-24 4 4 0001493152-25-019309 12268
2025-10-22 4 xslF345X05/ownership.xml 0001493152-25-018917 12253
2025-10-21 144 xsl144X01/primary_doc.xml 0001493152-25-018844 001-39083 251408415 33 11027
2025-10-17 4 4 0001493152-25-018462 12267
2025-10-14 4 4 0001493152-25-018021 12265
2025-10-09 4 xslF345X05/ownership.xml 0001493152-25-017612 12253
2025-10-07 4 4 0001493152-25-017300 12262
2025-10-03 144 xsl144X01/primary_doc.xml 0001493152-25-016892 001-39083 251374787 33 4973
2025-10-02 4 FORM 4 0001628280-25-043567 5243
2025-10-01 144 xsl144X01/primary_doc.xml 0001950047-25-007655 001-39083 251365075 33 6237
2025-09-03 4 FORM 4 0001197020-25-000005 5243
2025-08-06 10-Q 10-Q 0001628280-25-038431 001-39083 251190794 34 6151943 1 1
2025-08-06 8-K 8-K 2.02,9.01 0001628280-25-038329 001-39083 251189615 34 416873 1 1
2025-08-04 4 FORM 4 0001628280-25-037344 5243
2025-07-24 8-K 8-K 8.01,9.01 0001628280-25-035847 001-39083 251144724 34 281471 1 1
2025-07-17 4 FORM 4 0001628280-25-035269 6879
2025-07-17 144 xsl144X01/primary_doc.xml 0001950047-25-005079 001-39083 251130849 33 5479
2025-07-15 144 xsl144X01/primary_doc.xml 0001628280-25-034990 001-39083 251126015 33 4324
2025-07-02 4 FORM 4 0001628280-25-034055 5243
2025-07-01 144 xsl144X01/primary_doc.xml 0001950047-25-004753 001-39083 251096723 33 4788
2025-06-11 144 xsl144X01/primary_doc.xml 0001950047-25-004196 001-39083 251041102 33 6116
2025-06-10 144 xsl144X01/primary_doc.xml 0001950047-25-004113 001-39083 251037930 33 5410
2025-06-09 4 FORM 4 0001628280-25-030306 7328
2025-06-09 144 xsl144X01/primary_doc.xml 0001950047-25-004056 001-39083 251035303 33 4702
2025-06-06 4 FORM 4 0001628280-25-030078 6363
2025-06-02 4 FORM 4 0001628280-25-028902 273313
2025-06-02 4 FORM 4 0001628280-25-028900 271507
2025-06-02 4 FORM 4 0001628280-25-028898 271706
2025-06-02 4 FORM 4 0001628280-25-028896 273920
2025-06-02 4 FORM 4 0001628280-25-028894 272485
2025-06-02 4 FORM 4 0001628280-25-028892 272094
2025-06-02 4 FORM 4 0001628280-25-028890 271300
2025-06-02 4 FORM 4 0001628280-25-028888 273791
2025-06-02 144 xsl144X01/primary_doc.xml 0001950047-25-003685 001-39083 251015404 33 4822
2025-05-29 8-K 8-K 5.07 0001628280-25-028356 001-39083 251003702 34 184408 1 1
2025-05-09 8-K 8-K 8.01,9.01 0001628280-25-024067 001-39083 25928483 34 228145 1 1
2025-05-08 10-Q 10-Q 0001628280-25-023291 001-39083 25923030 34 6122158 1 1
2025-05-07 8-K 8-K 2.02,9.01 0001628280-25-023175 001-39083 25921517 34 431387 1 1
2025-04-28 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0002052113-25-001777 005-91177 25878648 34 11307
2025-04-17 ARS ARS 0001140361-25-014316 001-39083 25844481 34 3966168
2025-04-17 DEFA14A DEFA14A 0001628280-25-018122 001-39083 25844406 34 14543221
2025-04-17 DEF 14A DEF 14A 0001628280-25-018119 001-39083 25844388 34 17696209 1 1
2025-04-04 4 FORM 4 0001628280-25-016800 5706
2025-04-03 144 xsl144X01/primary_doc.xml 0001628280-25-016685 001-39083 25811623 33 4941
2025-02-27 4 FORM 4 0001628280-25-008499 5316
2025-02-27 S-8 S-8 0001628280-25-008248 333-285294 25672555 33 339929 1 1
2025-02-27 10-K 10-K 0001628280-25-008245 001-39083 25671640 34 26818337 1 1
2025-02-26 144 xsl144X01/primary_doc.xml 0001950047-25-001287 001-39083 25670474 33 6236
2025-02-26 8-K 8-K 2.02,9.01 0001628280-25-008163 001-39083 25670301 34 463964 1 1
2025-02-25 4 FORM 4 0001628280-25-007708 9178
2025-02-25 4 FORM 4 0001628280-25-007706 4850
2025-02-25 4 FORM 4 0001628280-25-007703 272364
2025-02-25 4 FORM 4 0001628280-25-007699 272690
2025-02-25 4 FORM 4 0001628280-25-007696 8593
2025-02-25 4 FORM 4 0001628280-25-007693 9463
2025-02-25 4 FORM 4 0001628280-25-007690 8576
2025-02-24 144 xsl144X01/primary_doc.xml 0001628280-25-007541 001-39083 25659026 33 5041
2025-02-24 144 xsl144X01/primary_doc.xml 0001628280-25-007540 001-39083 25659023 33 5059
2025-02-24 144 xsl144X01/primary_doc.xml 0001628280-25-007539 001-39083 25659019 33 152364
2025-02-24 144 xsl144X01/primary_doc.xml 0001628280-25-007537 001-39083 25658956 33 152946
2025-02-24 144 xsl144X01/primary_doc.xml 0001628280-25-007536 001-39083 25658952 33 153116
2025-02-19 4 FORM 4 0001628280-25-006516 9178
2025-02-18 144 xsl144X01/primary_doc.xml 0001628280-25-006190 001-39083 25636834 33 10516
2025-02-14 4 FORM 4 0001628280-25-005864 5098
2025-02-13 144 xsl144X01/primary_doc.xml 0001628280-25-005514 001-39083 25622264 33 10535
2025-01-30 8-K 8-K 5.02 0001628280-25-003073 001-39083 25571196 34 181522 1 1
2025-01-08 4 FORM 4 0001628280-25-000994 4741
2025-01-08 144 xsl144X01/primary_doc.xml 0001950047-25-000186 001-39083 25518791 33 4794
2025-01-08 8-K 8-K 7.01,8.01,9.01 0001193125-25-003214 001-39083 25516600 34 213665 1 1
2024-12-04 4 FORM 4 0001628280-24-049897 5208
2024-12-02 144 xsl144X01/primary_doc.xml 0001950047-24-009340 001-39083 241520036 33 6947
2024-11-18 4 FORM 4 0001628280-24-048230 6991
2024-11-07 4 FORM 4 0001628280-24-046462 4806
2024-11-06 144 xsl144X01/primary_doc.xml 0001950047-24-008158 001-39083 241431917 33 5590
2024-11-05 4 FORM 4 0001628280-24-045387 6919
2024-11-05 144 xsl144X01/primary_doc.xml 0001950047-24-008105 001-39083 241427828 33 4823
2024-11-04 10-Q 10-Q 0001628280-24-044995 001-39083 241423582 34 7865400 1 1
2024-10-31 8-K 8-K 2.02,9.01 0001628280-24-044563 001-39083 241415523 34 352591 1 1
2024-10-24 4 FORM 4 0001628280-24-043632 11564
2024-10-18 SC 13G/A Vir_Biotechnology_Inc.htm 0000093751-24-000892 005-91177 241379652 34 55974
2024-10-03 3 FORM 3 0001628280-24-042178 297771
2024-10-02 3 FORM 3 0001628280-24-041830 300033
2024-10-02 3 FORM 3 0001628280-24-041828 303868
2024-09-10 4 FORM 4 0001628280-24-040035 5267
2024-09-10 8-K 8-K 2.01,5.02,7.01,9.01 0001628280-24-039948 001-39083 241288777 34 306661 1 1
2024-09-09 144 xsl144X01/primary_doc.xml 0001950047-24-006897 001-39083 241287589 33 4994
2024-08-01 10-Q 10-Q 0001628280-24-034195 001-39083 241167439 34 6428833 1 1
2024-08-01 8-K 8-K 2.02,2.05,9.01 0001628280-24-034143 001-39083 241166745 34 352596 1 1
2024-08-01 8-K 8-K 1.01 0001193125-24-191500 001-39083 241166681 34 151823 1 1
2024-07-16 4 4 0000950170-24-083951 6894
2024-07-10 144 xsl144X01/primary_doc.xml 0001972362-24-000951 001-39083 241109829 33 4442
2024-06-26 8-K 8-K 8.01,9.01 0001193125-24-168554 001-39083 241070679 34 176179 1 1
2024-06-12 4 FORM 4 0001628280-24-027797 6435
2024-06-12 4 FORM 4 0001628280-24-027760 4479
2024-06-11 144 xsl144X01/primary_doc.xml 0001972362-24-000891 001-39083 241036548 33 4772
2024-06-07 144 xsl144X01/primary_doc.xml 0001972362-24-000867 001-39083 241030504 33 4287
2024-06-05 8-K 8-K 7.01,9.01 0001193125-24-154636 001-39083 241020632 34 222186 1 1
2024-06-03 4 FORM 4 0001628280-24-026221 7423
2024-06-03 4 FORM 4 0001628280-24-026219 10125
2024-06-03 4 FORM 4 0001628280-24-026217 6534
2024-06-03 4 FORM 4 0001628280-24-026215 6491
2024-06-03 4 FORM 4 0001628280-24-026213 9965
2024-06-03 4 FORM 4 0001628280-24-026211 6552
2024-06-03 4 FORM 4 0001628280-24-026207 7652
2024-06-03 4 FORM 4 0001628280-24-026193 6503
2024-06-03 3 FORM 3 0001628280-24-026190 302367
2024-05-31 4 FORM 4 0001628280-24-025999 8948
2024-05-31 3 FORM 3 0001628280-24-025998 302401
2024-05-31 4 FORM 4 0001628280-24-025997 8968
2024-05-31 3 FORM 3 0001628280-24-025995 303862
2024-05-29 8-K 8-K 5.07 0001193125-24-149139 001-39083 24998344 34 152071 1 1
2024-05-14 DEFA14A DEFA14A 0001193125-24-138206 001-39083 24944228 34 2222999
2024-05-03 10-Q 10-Q 0001628280-24-020299 001-39083 24913332 34 5601899 1 1
2024-05-02 8-K 8-K 2.02,9.01 0001628280-24-020009 001-39083 24908289 34 367924 1 1
2024-04-19 ARS ARS 0001140361-24-020688 001-39083 24855751 34 2412480
2024-04-19 DEFA14A DEFA14A 0001140361-24-020686 001-39083 24855700 34 861525
2024-04-19 DEF 14A DEF 14A 0001140361-24-020684 001-39083 24855696 34 9837419 1 1
2024-04-18 8-K 8-K 5.02,8.01,9.01 0001193125-24-100072 001-39083 24852964 34 175402 1 1
2024-04-04 4 FORM 4 0001628280-24-014878 4807
2024-04-04 144 xsl144X01/primary_doc.xml 0001972362-24-000490 001-39083 24822964 33 6112
2024-04-03 144 xsl144X01/primary_doc.xml 0001950047-24-002911 001-39083 24818861 33 9270
2024-04-02 4 FORM 4 0001628280-24-014468 5709
2024-03-28 4 FORM 4 0001628280-24-013555 4751
2024-02-26 4 FORM 4 0001628280-24-006985 9490
2024-02-26 4 FORM 4 0001628280-24-006984 6945
2024-02-26 4 FORM 4 0001628280-24-006983 6886
2024-02-26 4 FORM 4 0001628280-24-006982 4838
2024-02-26 4 FORM 4 0001628280-24-006980 10434
2024-02-26 144 xsl144X01/primary_doc.xml 0001950047-24-001409 001-39083 24679448 33 5552
2024-02-26 S-8 S-8 0001193125-24-046227 333-277358 24679336 33 95622
2024-02-26 10-K 10-K 0001628280-24-006852 001-39083 24678794 34 12115984 1 1
2024-02-22 8-K 8-K 1.01,2.02,9.01 0001628280-24-006346 001-39083 24664869 34 428128 1 1
2024-02-20 4 FORM 4 0001628280-24-005747 10434
2024-02-20 144 xsl144X01/primary_doc.xml 0001950047-24-001151 001-39083 24654109 33 4790
2024-02-20 8-K 8-K 5.02 0001193125-24-040034 001-39083 24654037 34 142090 1 1
2024-02-16 4 FORM 4 0001628280-24-005418 4837
2024-02-13 SC 13G/A SCHEDULE 13G/A 0001104659-24-022248 005-91177 24629891 34 13084
2024-02-13 SC 13G/A formsc13ga.htm 0001493152-24-006178 005-91177 24627560 34 124081
2024-01-24 SC 13G Vir_Biotech_Inc.txt 0000093751-24-000114 005-91177 24554269 34 8531
2024-01-23 SC 13G/A us92764n1028_012324.txt 0001086364-24-001765 005-91177 24552785 34 13682
2024-01-03 4 FORM 4 0001628280-24-000169 13988
2023-12-13 8-K 8-K 2.05 0001193125-23-294328 001-39083 231484012 34 150231 1 1
2023-11-03 8-K 8-K 1.01,1.02 0001193125-23-270462 001-39083 231376970 34 148048 1 1
2023-11-03 S-3ASR S-3ASR 0001193125-23-270443 333-275314 231376893 33 1414504
2023-11-03 10-Q 10-Q 0001628280-23-036702 001-39083 231376325 34 6520653 1 1
2023-11-02 8-K 8-K 2.02,9.01 0001628280-23-036397 001-39083 231372346 34 394905 1 1
2023-10-20 4 FORM 4 0001628280-23-034785 7437
2023-10-18 4 FORM 4 0001628280-23-034571 11471
2023-10-03 8-K 8-K 1.01 0001193125-23-249556 001-39083 231301584 34 153714 1 1
2023-09-20 8-K 8-K 5.02 0001193125-23-237943 001-39083 231265219 34 142501 1 1
2023-09-18 4 FORM 4 SUBMISSION 0001209191-23-049722 20565
2023-08-04 10-Q 10-Q 0001628280-23-027527 001-39083 231143935 34 5995110 1 1
2023-08-03 8-K 8-K 2.02,9.01 0001628280-23-027227 001-39083 231140170 34 378530 1 1
2023-07-20 8-K 8-K 2.02,8.01,9.01 0001193125-23-190147 001-39083 231098122 34 205962 1 1
2023-07-05 4 FORM 4 SUBMISSION 0000899243-23-017010 9220
2023-07-03 4 FORM 4 SUBMISSION 0001209191-23-040563 5282
2023-06-30 4 FORM 4 SUBMISSION 0000899243-23-016775 11972
2023-06-30 144 xsl144X01/primary_doc.xml 0001950047-23-002016 001-39083 231062726 33 4630
2023-06-29 144 xsl144X01/primary_doc.xml 0001961863-23-000060 001-39083 231058265 33 19093
2023-06-22 4 FORM 4 SUBMISSION 0000899243-23-016308 9734
2023-06-20 4 FORM 4 SUBMISSION 0000899243-23-016075 16456
2023-06-15 4 FORM 4 SUBMISSION 0000899243-23-015663 16461
2023-06-08 4 FORM 4 SUBMISSION 0001209191-23-035409 12884
2023-06-07 144 xsl144X01/primary_doc.xml 0001950047-23-001365 001-39083 23999071 33 4724
2023-06-06 4 FORM 4 SUBMISSION 0000899243-23-014628 11969
2023-06-05 144 xsl144X01/primary_doc.xml 0001972362-23-000299 001-39083 23994150 33 4183
2023-06-02 4 FORM 4 SUBMISSION 0001209191-23-033551 8622
2023-06-02 4 FORM 4 SUBMISSION 0001209191-23-033550 4721
2023-06-01 144 xsl144X01/primary_doc.xml 0001950047-23-001147 001-39083 23985098 33 4660
2023-06-01 144 xsl144X01/primary_doc.xml 0001950047-23-001137 001-39083 23985060 33 4603
2023-05-25 4 FORM 4 SUBMISSION 0000899243-23-013936 20936
2023-05-24 4 FORM 4 SUBMISSION 0001209191-23-031882 13731
2023-05-24 4 FORM 4 SUBMISSION 0001209191-23-031850 10339
2023-05-24 4 FORM 4 SUBMISSION 0001209191-23-031848 10301
2023-05-24 4 FORM 4 SUBMISSION 0001209191-23-031846 10364
2023-05-24 4 FORM 4 SUBMISSION 0001209191-23-031845 11748
2023-05-24 4 FORM 4 SUBMISSION 0001209191-23-031843 10328
2023-05-24 4 FORM 4 SUBMISSION 0001209191-23-031842 13243
2023-05-24 4 FORM 4 SUBMISSION 0001209191-23-031841 10340
2023-05-24 4 FORM 4 SUBMISSION 0001209191-23-031840 11115
2023-05-23 4 FORM 4 SUBMISSION 0000899243-23-013759 11970
2023-05-23 8-K 8-K 5.07 0000950170-23-023627 001-39083 23948967 34 225343 1 1
2023-05-19 144 xsl144X01/primary_doc.xml 0001961863-23-000022 001-39083 23940368 33 4666
2023-05-09 4 FORM 4 SUBMISSION 0000899243-23-012478 9728
2023-05-08 10-Q 10-Q 0000950170-23-018789 001-39083 23897737 34 9567406 1 1
2023-05-05 4 FORM 4 SUBMISSION 0000899243-23-012410 11970
2023-05-04 8-K 8-K 2.02,9.01 0000950170-23-017880 001-39083 23888963 34 541889 1 1
2023-05-03 4 FORM 4 SUBMISSION 0000899243-23-012176 9729
2023-04-26 4 FORM 4 SUBMISSION 0000899243-23-011791 11970
2023-04-24 4 FORM 4 SUBMISSION 0000899243-23-011617 14212
2023-04-20 4 FORM 4 SUBMISSION 0000899243-23-011512 11971
2023-04-18 4 FORM 4 SUBMISSION 0000899243-23-011414 11970
2023-04-07 ARS ARS 0001193125-23-095234 001-39083 23808879 34 12473312
2023-04-07 DEFA14A DEFA14A 0001193125-23-095223 001-39083 23808864 34 103895
2023-04-07 DEF 14A DEF 14A 0001193125-23-095213 001-39083 23808842 34 2765901 1 1
2023-04-04 4 FORM 4 SUBMISSION 0001209191-23-022777 7202
2023-04-04 3 FORM 3 SUBMISSION 0001209191-23-022768 6581
2023-03-31 4 FORM 4 SUBMISSION 0001209191-23-021853 9314
2023-03-29 4 FORM 4 SUBMISSION 0001209191-23-021548 7152
2023-03-29 3 FORM 3 SUBMISSION 0001209191-23-021546 6543
2023-03-13 8-K 8-K 7.01 0001193125-23-067978 001-39083 23725482 34 145164 1 1
2023-03-09 4 FORM 4 SUBMISSION 0001209191-23-017483 5252
2023-03-08 8-K 8-K 5.03,9.01 0001193125-23-064485 001-39083 23716162 34 363109 1 1
2023-03-07 4 FORM 4 SUBMISSION 0001209191-23-016629 4868
2023-03-02 4 FORM 4 SUBMISSION 0001209191-23-014673 6207
2023-02-28 4 FORM 4 SUBMISSION 0001209191-23-013683 7445
2023-02-28 S-8 S-8 0000950170-23-005145 333-270108 23686130 33 432417
2023-02-28 10-K 10-K 0000950170-23-005118 001-39083 23685790 34 22566849 1 1
2023-02-24 4 FORM 4 SUBMISSION 0001209191-23-013007 4799
2023-02-24 4 FORM 4 SUBMISSION 0001209191-23-013006 10028
2023-02-24 4 FORM 4 SUBMISSION 0001209191-23-013004 14664
2023-02-24 4 FORM 4 SUBMISSION 0001209191-23-012996 8943
2023-02-24 4 FORM 4 SUBMISSION 0001209191-23-012994 8954
2023-02-24 4 FORM 4 SUBMISSION 0001209191-23-012991 7212
2023-02-23 4 FORM 4 SUBMISSION 0000899243-23-006057 15913
2023-02-23 8-K 8-K 2.02,9.01 0000950170-23-004092 001-39083 23659592 34 624695 1 1
2023-02-22 8-K 8-K 8.01 0001193125-23-044204 001-39083 23650622 34 142098 1 1
2023-02-21 4 FORM 4 SUBMISSION 0001209191-23-011387 20720
2023-02-21 4 FORM 4 SUBMISSION 0001209191-23-011385 5059
2023-02-21 4 FORM 4 SUBMISSION 0001209191-23-011384 4837
2023-02-21 4 FORM 4 SUBMISSION 0001209191-23-011382 4799
2023-02-17 4 FORM 4 SUBMISSION 0000899243-23-005577 9698
2023-02-16 8-K 8-K 5.02 0001193125-23-040755 001-39083 23637246 34 153501 1 1
2023-02-15 4 FORM 4 SUBMISSION 0000899243-23-005183 14179
2023-02-14 SC 13G/A SC 13G/A 0001193125-23-039075 005-91177 23629079 34 80843
2023-02-13 4 FORM 4 SUBMISSION 0000899243-23-004850 18659
2023-02-13 8-K 8-K 1.01 0001193125-23-035908 001-39083 23619000 34 146216 1 1
2023-02-09 4 FORM 4 SUBMISSION 0000899243-23-004510 18145
2023-02-09 SC 13G/A SCHEDULE 13G/A 0001104659-23-017253 005-91177 23604540 34 13019
2023-02-09 4 FORM 4 SUBMISSION 0001209191-23-007976 6816
2023-02-07 4 FORM 4 SUBMISSION 0000899243-23-004262 16418
2023-02-03 4 FORM 4 SUBMISSION 0000899243-23-003957 14182
2023-02-01 4 FORM 4 SUBMISSION 0000899243-23-003181 16420
2023-01-25 4 FORM 4 SUBMISSION 0000899243-23-002713 11934
2023-01-25 4 FORM 4 SUBMISSION 0001209191-23-004945 13179
2023-01-25 8-K 8-K 5.02 0001193125-23-014834 001-39083 23549898 34 159660 1 1
2023-01-24 SC 13G/A us92764n1028_012423.txt 0001306550-23-002937 005-91177 23547322 34 13453
2023-01-23 4 FORM 4 SUBMISSION 0000899243-23-002444 16417
2023-01-19 4 FORM 4 SUBMISSION 0000899243-23-002222 11941
2023-01-17 4 FORM 4 SUBMISSION 0000899243-23-001914 14179
2023-01-12 4 FORM 4 SUBMISSION 0000899243-23-001707 14175
2023-01-11 4 FORM 4 SUBMISSION 0001209191-23-002917 5253
2023-01-10 4 FORM 4 SUBMISSION 0000899243-23-001530 16415
2023-01-09 4 FORM 4 SUBMISSION 0001209191-23-002507 6205
2023-01-05 4 FORM 4 SUBMISSION 0000899243-23-001123 11935
2023-01-05 4 FORM 4 SUBMISSION 0001209191-23-001932 8472
2023-01-03 4 FORM 4 SUBMISSION 0000899243-23-000445 9698
2022-12-29 4 FORM 4 SUBMISSION 0000899243-22-039557 9700
2022-12-27 4 FORM 4 SUBMISSION 0000899243-22-039418 16425
2022-12-22 4 FORM 4 SUBMISSION 0000899243-22-039249 14182
2022-12-09 4 FORM 4 SUBMISSION 0001209191-22-060463 5254
2022-12-06 4 FORM 4 SUBMISSION 0000899243-22-037824 11940
2022-12-02 4 FORM 4 SUBMISSION 0000899243-22-037480 16425
2022-11-30 4 FORM 4 SUBMISSION 0000899243-22-037247 14181
2022-11-28 4 FORM 4 SUBMISSION 0000899243-22-037092 11941
2022-11-23 4 FORM 4 SUBMISSION 0000899243-22-036931 9701
2022-11-22 4 FORM 4 SUBMISSION 0000899243-22-036796 11936
2022-11-18 4 FORM 4 SUBMISSION 0000899243-22-036376 14183
2022-11-16 4 FORM 4 SUBMISSION 0000899243-22-036073 14183
2022-11-14 4 FORM 4 SUBMISSION 0000899243-22-035695 14182
2022-11-09 4 FORM 4 SUBMISSION 0000899243-22-035439 11958
2022-11-09 4 FORM 4 SUBMISSION 0001209191-22-056178 5253
2022-11-03 10-Q 10-Q 0000950170-22-021854 001-39083 221358008 34 11998566 1 1
2022-11-03 8-K 8-K 2.02,9.01 0000950170-22-021846 001-39083 221357958 34 641352 1 1
2022-10-11 4 FORM 4 SUBMISSION 0001209191-22-053239 5254
2022-10-04 8-K 8-K 8.01,9.01 0001193125-22-257259 001-39083 221289791 34 178778 1 1
2022-09-13 SC 13D/A ARCH VENTURE FUND IX, L.P. -- VIR BIOTECHNOLOGY, INC. -- SCHEDULE 13DA(#6) 0001072613-22-000558 005-91177 221240670 34 287906
2022-09-09 4 FORM 4 SUBMISSION 0001209191-22-049284 5254
2022-09-08 SC 13G us92764n1028_090722.txt 0000834237-22-010641 005-91177 221233341 34 13473
2022-09-07 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-019343 16909
2022-09-07 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-019342 30775
2022-09-01 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-018985 16909

Latest XBRL company facts

One latest value per concept from companyfacts (311 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 171.27M 2026-10-28 2026 Q3 10-Q 2026-11-04 0001628280-26-070273
dei EntityPublicFloat Entity Public Float USD 689.20M 2025-06-30 2025 FY 10-K 2026-02-23 0001628280-26-010749
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 1.29M 2025-01-01 2025-12-31 DEF 14A 2026-04-16 0001628280-26-025379
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 2.00M 2025-01-01 2025-12-31 DEF 14A 2026-04-16 0001628280-26-025379
ecd PeerGroupTotalShareholderRtnAmt PeerGroupTotalShareholderRtnAmt USD 124.75 2025-01-01 2025-12-31 DEF 14A 2026-04-16 0001628280-26-025379
ecd PeoActuallyPaidCompAmt PeoActuallyPaidCompAmt USD 3.10M 2025-01-01 2025-12-31 DEF 14A 2026-04-16 0001628280-26-025379
ecd PeoTotalCompAmt PeoTotalCompAmt USD 7.83M 2025-01-01 2025-12-31 DEF 14A 2026-04-16 0001628280-26-025379
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 22.52 2025-01-01 2025-12-31 DEF 14A 2026-04-16 0001628280-26-025379
ffd NetFeeAmt NetFeeAmt USD 0 2026-11-16 424B5 2026-11-16 0001193125-26-462355
ffd NrrtvMaxAggtOfferingPric NrrtvMaxAggtOfferingPric USD 172.50M 2026-11-16 424B5 2026-11-16 0001193125-26-462355
ffd TtlFeeAmt TtlFeeAmt USD 15,007.5 2026-11-16 424B5 2026-11-16 0001193125-26-462355
ffd TtlOfferingAmt TtlOfferingAmt USD 172.50M 2026-11-16 424B5 2026-11-16 0001193125-26-462355
ffd TtlOffsetAmt TtlOffsetAmt USD 15,007.5 2026-11-16 424B5 2026-11-16 0001193125-26-462355
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 0 2026-11-16 424B5 2026-11-16 0001193125-26-462355
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 11.32M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070273
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 0 2022-12-31 2022 FY 10-K 2023-02-28 0000950170-23-005118
us-gaap AccretionAmortizationOfDiscountsAndPremiumsInvestments Accretion (Amortization) of Discounts and Premiums, Investments USD 26,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070273
us-gaap AccruedIncomeTaxesCurrent Accrued Income Taxes, Current USD 17,000 2024-06-30 2024 Q2 10-Q 2024-08-01 0001628280-24-034195
us-gaap AccruedLiabilitiesAndOtherLiabilities Accrued Liabilities and Other Liabilities USD 69.33M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070273
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 26.50M 2019-12-31 2019 FY 10-K 2020-03-26 0001564590-20-013194
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 5.22M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070273
us-gaap AccruedRoyaltiesCurrent Accrued Royalties, Current USD 1.14M 2024-06-30 2024 Q2 10-Q 2024-08-01 0001628280-24-034195
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 55.32M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070273
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -6.90M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070273
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 2.24B 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070273
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 34.93M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070273
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD 10.29M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070273
us-gaap AdjustmentsToAdditionalPaidInCapitalStockSplit Adjustments to Additional Paid in Capital, Stock Split USD 3,000 2019-01-01 2019-12-31 2021 FY 10-K 2022-02-28 0000950170-22-002295
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 34.93M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070273
us-gaap AmortizationOfIntangibleAssets Amortization of Intangible Assets USD 531,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-26 0001628280-24-006852
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 15.90M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070273
us-gaap AssetImpairmentCharges Asset Impairment Charges USD 5.40M 2023-04-01 2023-06-30 2024 Q3 10-Q 2024-11-04 0001628280-24-044995
us-gaap Assets Assets USD 1.11B 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070273
us-gaap AssetsCurrent Assets, Current USD 508.27M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070273
us-gaap AssetsFairValueAdjustment Assets, Fair Value Adjustment USD 2.30M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070273
us-gaap AssetsFairValueDisclosure Assets, Fair Value Disclosure USD 858.63M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070273
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 101,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070273
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 3.94M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070273
us-gaap BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability USD -17.50M 2025-01-01 2025-03-31 2025 FY 10-K 2026-02-23 0001628280-26-010749
us-gaap BusinessCombinationContingentConsiderationLiability Business Combination, Contingent Consideration, Liability USD 1.50M 2022-12-31 2022 FY 10-K 2023-02-28 0000950170-23-005118
us-gaap BusinessCombinationContingentConsiderationLiabilityCurrent Business Combination, Contingent Consideration, Liability, Current USD 0 2025-12-31 2025 FY 10-K 2026-02-23 0001628280-26-010749
us-gaap BusinessCombinationContingentConsiderationLiabilityNoncurrent Business Combination, Contingent Consideration, Liability, Noncurrent USD 32.98M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070273
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 1.02M 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-28 0000950170-23-005118
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 218.87M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070273
us-gaap CashCashEquivalentsAndShortTermInvestments Cash, Cash Equivalents, and Short-term Investments USD 1.19B 2024-09-30 2024 Q3 10-Q 2024-11-04 0001628280-24-044995
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 227.71M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070273
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -13.36M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070273
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070273
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 300.00M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070273
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 169.41M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070273
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 169.41M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070273
us-gaap CommonStockValue Common Stock, Value, Issued USD 17,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070273
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -146.71M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070273
us-gaap ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-23 0001628280-26-010749
us-gaap ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest USD -438.33M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-23 0001628280-26-010749
us-gaap ContractWithCustomerAssetNetCurrent Contract with Customer, Asset, after Allowance for Credit Loss, Current USD 112.50M 2021-03-31 2021 Q1 10-Q 2021-05-06 0001564590-21-024948
us-gaap ContractWithCustomerLiabilityCurrent Contract with Customer, Liability, Current USD 0 2025-12-31 2025 FY 10-K 2026-02-23 0001628280-26-010749
us-gaap ContractWithCustomerLiabilityNoncurrent Contract with Customer, Liability, Noncurrent USD 9.43M 2025-09-30 2025 Q3 10-Q 2025-11-05 0001628280-25-049694
us-gaap CostOfRevenue Cost of Revenue USD 0 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-05 0001628280-26-053549
us-gaap CostsAndExpenses Costs and Expenses USD 402.21M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070273
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD 162,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-23 0001628280-26-010749
us-gaap CurrentForeignTaxExpenseBenefit Current Foreign Tax Expense (Benefit) USD -261,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-23 0001628280-26-010749
us-gaap CurrentIncomeTaxExpenseBenefit Current Income Tax Expense (Benefit) USD -87,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-23 0001628280-26-010749
us-gaap CurrentStateAndLocalTaxExpenseBenefit Current State and Local Tax Expense (Benefit) USD 12,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-23 0001628280-26-010749
us-gaap DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss Debt Securities, Available-for-Sale, Accrued Interest, after Allowance for Credit Loss USD 5.40M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070273
us-gaap DebtSecuritiesAvailableForSaleAccruedInterestWriteoff Debt Securities, Available-for-Sale, Accrued Interest Writeoff USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070273
us-gaap DebtSecuritiesAvailableForSaleAllowanceForCreditLoss Debt Securities, Available-for-sale, Allowance for Credit Loss USD 0 2025-12-31 2025 FY 10-K 2026-02-23 0001628280-26-010749
us-gaap DebtSecuritiesAvailableForSaleUnrealizedGainLoss Debt Securities, Available-for-sale, Unrealized Gain (Loss) USD -3.80M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070273
us-gaap DeferredFederalIncomeTaxExpenseBenefit Deferred Federal Income Tax Expense (Benefit) USD 302,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-23 0001628280-26-010749
us-gaap DeferredForeignIncomeTaxExpenseBenefit Deferred Foreign Income Tax Expense (Benefit) USD 2,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-23 0001628280-26-010749
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD 304,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-23 0001628280-26-010749
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 22.11M 2025-12-31 2025 FY 10-K 2026-02-23 0001628280-26-010749
us-gaap DeferredIncomeTaxLiabilitiesNet Deferred Income Tax Liabilities, Net USD 3.25M 2023-03-31 2023 Q1 10-Q 2023-05-08 0000950170-23-018789
us-gaap DeferredRevenueCurrent Deferred Revenue, Current USD 0 2025-09-30 2025 Q3 10-Q 2025-11-05 0001628280-25-049694
us-gaap DeferredRevenueNoncurrent Deferred Revenue, Noncurrent USD 1.53M 2024-03-31 2024 Q1 10-Q 2024-05-03 0001628280-24-020299
us-gaap DeferredStateAndLocalIncomeTaxExpenseBenefit Deferred State and Local Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-23 0001628280-26-010749
us-gaap DeferredTaxAssetsGoodwillAndIntangibleAssets Deferred Tax Assets, Goodwill and Intangible Assets USD 61.27M 2025-12-31 2025 FY 10-K 2026-02-23 0001628280-26-010749
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 249.72M 2022-12-31 2022 FY 10-K 2023-02-28 0000950170-23-005118
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 118.47M 2025-12-31 2025 FY 10-K 2026-02-23 0001628280-26-010749
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 454,000 2025-12-31 2025 FY 10-K 2026-02-23 0001628280-26-010749
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 22.56M 2025-12-31 2025 FY 10-K 2026-02-23 0001628280-26-010749
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 294.59M 2025-12-31 2025 FY 10-K 2026-02-23 0001628280-26-010749
us-gaap DeferredTaxAssetsPropertyPlantAndEquipment Deferred Tax Assets, Property, Plant and Equipment USD 8.18M 2019-12-31 2019 FY 10-K 2020-03-26 0001564590-20-013194
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 35.58M 2025-12-31 2025 FY 10-K 2026-02-23 0001628280-26-010749
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 14.78M 2025-12-31 2025 FY 10-K 2026-02-23 0001628280-26-010749
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals USD 6.71M 2025-12-31 2025 FY 10-K 2026-02-23 0001628280-26-010749
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 527.11M 2025-12-31 2025 FY 10-K 2026-02-23 0001628280-26-010749
us-gaap DeferredTaxLiabilities Deferred Tax Liabilities, Net USD 2.19M 2023-12-31 2024 FY 10-K 2025-02-27 0001628280-25-008245
us-gaap DeferredTaxLiabilitiesOther Deferred Tax Liabilities, Other USD 257,000 2025-12-31 2025 FY 10-K 2026-02-23 0001628280-26-010749
us-gaap DeferredTaxLiabilitiesPropertyPlantAndEquipment Deferred Tax Liabilities, Property, Plant and Equipment USD 9.00M 2025-12-31 2025 FY 10-K 2026-02-23 0001628280-26-010749
us-gaap DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities Deferred Tax Liabilities, Unrealized Gains on Trading Securities USD 1.19M 2023-12-31 2023 FY 10-K 2024-02-26 0001628280-24-006852
us-gaap DefinedContributionPlanCostRecognized Defined Contribution Plan, Cost USD 3.40M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-23 0001628280-26-010749
us-gaap Depreciation Depreciation USD 8.10M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070273
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 8.38M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070273
us-gaap DerivativeGainLossOnDerivativeNet Derivative, Gain (Loss) on Derivative, Net USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-28 0000950170-23-005118
us-gaap DerivativeLiabilitiesCurrent Derivative Liability, Current USD 12.45M 2019-12-31 2020 FY 10-K 2021-02-25 0001564590-21-008915
us-gaap DividendsPayableCurrentAndNoncurrent Dividends Payable USD 0 2019-09-30 2019 Q3 10-Q 2019-11-19 0001564590-19-043877
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -0.88 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070273
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -1.32 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-06 0001564590-21-024948
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -0.88 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070273
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure -0.001 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070273
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-23 0001628280-26-010749
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.174 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-23 0001628280-26-010749
us-gaap EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent pure 0.005 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-23 0001628280-26-010749
us-gaap EffectiveIncomeTaxRateReconciliationGiltiAmount EffectiveIncomeTaxRateReconciliationGiltiAmount USD 3.56M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-23 0001628280-26-010749
us-gaap EffectiveIncomeTaxRateReconciliationGiltiPercent EffectiveIncomeTaxRateReconciliationGiltiPercent pure -0.008 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-23 0001628280-26-010749
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure -0.035 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-23 0001628280-26-010749
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure 0.003 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-23 0001628280-26-010749
us-gaap EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Percent pure 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-28 0000950170-23-005118
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-23 0001628280-26-010749
us-gaap EffectiveIncomeTaxRateReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Percent pure -0.002 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-23 0001628280-26-010749
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure -0.009 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-23 0001628280-26-010749
us-gaap EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent Effective Income Tax Rate Reconciliation, Tax Cuts and Jobs Act, Percent pure -6.8 2017-01-01 2017-12-31 2019 FY 10-K 2020-03-26 0001564590-20-013194
us-gaap EquitySecuritiesFvNi Equity Securities, FV-NI USD 3.72M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070273
us-gaap EquitySecuritiesFvNiCurrentAndNoncurrent EquitySecuritiesFvNiCurrentAndNoncurrent USD 5.90M 2026-03-31 2026 Q1 10-Q 2026-05-07 0001628280-26-031471
us-gaap EquitySecuritiesFvNiUnrealizedGainLoss Equity Securities, FV-NI, Unrealized Gain (Loss) USD -2.30M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070273
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD 2.05M 2019-01-01 2019-12-31 2021 FY 10-K 2022-02-28 0000950170-22-002295
us-gaap FairValueAssetsLevel1ToLevel2TransfersAmount Fair Value, Assets, Level 1 to Level 2 Transfers, Amount USD 0 2019-09-30 2019 Q3 10-Q 2019-11-19 0001564590-19-043877
us-gaap FairValueAssetsLevel2ToLevel1TransfersAmount Fair Value, Assets, Level 2 to Level 1 Transfers, Amount USD 0 2019-09-30 2019 Q3 10-Q 2019-11-19 0001564590-19-043877
us-gaap FairValueLiabilitiesLevel1ToLevel2TransfersAmount Fair Value, Liabilities, Level 1 to Level 2 Transfers, Amount USD 0 2019-09-30 2019 Q3 10-Q 2019-11-19 0001564590-19-043877
us-gaap FairValueLiabilitiesLevel2ToLevel1TransfersAmount Fair Value, Liabilities, Level 2 to Level 1 Transfers, Amount USD 0 2019-09-30 2019 Q3 10-Q 2019-11-19 0001564590-19-043877
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers Into Level 3 USD 0 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-19 0001564590-19-043877
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers out of Level 3 USD 0 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-19 0001564590-19-043877
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3 USD 0 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-19 0001564590-19-043877
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3 USD 0 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-19 0001564590-19-043877
us-gaap FinanceLeaseLiabilityCurrent Finance Lease, Liability, Current USD 265,000 2020-12-31 2020 FY 10-K 2021-02-25 0001564590-21-008915
us-gaap FinanceLeaseLiabilityNoncurrent Finance Lease, Liability, Noncurrent USD 700,000 2020-12-31 2020 FY 10-K 2021-02-25 0001564590-21-008915
us-gaap FinanceLeasePrincipalPayments Finance Lease, Principal Payments USD 0 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-08 0001628280-25-023291
us-gaap FinancingReceivableAccruedInterestWriteoff Financing Receivable, Accrued Interest, Writeoff USD 0 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-03 0001628280-24-020299
us-gaap FiniteLivedIntangibleAssetsAccumulatedAmortization Finite-Lived Intangible Assets, Accumulated Amortization USD 3.85M 2025-12-31 2025 FY 10-K 2026-02-23 0001628280-26-010749
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths Finite-Lived Intangible Asset, Expected Amortization, Year One USD 296,000 2025-12-31 2025 FY 10-K 2026-02-23 0001628280-26-010749
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFive Finite-Lived Intangible Asset, Expected Amortization, Year Five USD 36,000 2025-12-31 2025 FY 10-K 2026-02-23 0001628280-26-010749
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFour Finite-Lived Intangible Asset, Expected Amortization, Year Four USD 241,000 2025-12-31 2025 FY 10-K 2026-02-23 0001628280-26-010749
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearThree Finite-Lived Intangible Asset, Expected Amortization, Year Three USD 296,000 2025-12-31 2025 FY 10-K 2026-02-23 0001628280-26-010749
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo Finite-Lived Intangible Asset, Expected Amortization, Year Two USD 296,000 2025-12-31 2025 FY 10-K 2026-02-23 0001628280-26-010749
us-gaap FiniteLivedIntangibleAssetsGross Finite-Lived Intangible Assets, Gross USD 5.17M 2025-12-31 2025 FY 10-K 2026-02-23 0001628280-26-010749
us-gaap FiniteLivedIntangibleAssetsNet Finite-Lived Intangible Assets, Net USD 1.33M 2025-12-31 2025 FY 10-K 2026-02-23 0001628280-26-010749
us-gaap GainLossOnDispositionOfAssets1 Gain (Loss) on Disposition of Assets USD -2.30M 2024-04-01 2024-06-30 2024 Q2 10-Q 2024-08-01 0001628280-24-034195
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD -345,000 2019-01-01 2019-12-31 2020 FY 10-K 2021-02-25 0001564590-21-008915
us-gaap GainLossOnTerminationOfLease Gain (Loss) on Termination of Lease USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-26 0001628280-24-006852
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 25.74M 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-06 0001564590-21-024948
us-gaap Goodwill Goodwill USD 16.94M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070273
us-gaap GoodwillImpairmentLoss Goodwill, Impairment Loss USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-23 0001628280-26-010749
us-gaap ImpairmentOfIntangibleAssetsExcludingGoodwill Impairment of Intangible Assets (Excluding Goodwill) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-23 0001628280-26-010749
us-gaap ImpairmentOfIntangibleAssetsFinitelived Impairment of Intangible Assets, Finite-lived USD 9.66M 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-26 0001628280-24-006852
us-gaap ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-28 0000950170-23-005118
us-gaap ImpairmentOfLongLivedAssetsHeldForUse Impairment of Long-Lived Assets Held-for-use USD 7.66M 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-26 0001628280-24-006852
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD -448.37M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-23 0001628280-26-010749
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -141.66M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070273
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD 10.60M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-23 0001628280-26-010749
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 184,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070273
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 206,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070273
us-gaap IncomeTaxPaidFederalAfterRefundReceived IncomeTaxPaidFederalAfterRefundReceived USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-23 0001628280-26-010749
us-gaap IncomeTaxPaidStateAndLocalAfterRefundReceived IncomeTaxPaidStateAndLocalAfterRefundReceived USD 73,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-23 0001628280-26-010749
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 76.31M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-23 0001628280-26-010749
us-gaap IncomeTaxReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount USD -2.22M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-23 0001628280-26-010749
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -91.93M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-23 0001628280-26-010749
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD 15.34M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-23 0001628280-26-010749
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD -1.12M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-23 0001628280-26-010749
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD 9,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-23 0001628280-26-010749
us-gaap IncomeTaxReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Amount USD 1.02M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-23 0001628280-26-010749
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD 3.90M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-23 0001628280-26-010749
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 1.65M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070273
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD 6.51M 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-27 0001628280-25-008245
us-gaap IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities USD -15.04M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070273
us-gaap IncreaseDecreaseInDeferredIncomeTaxes Increase (Decrease) in Deferred Income Taxes USD 1.06M 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-26 0001628280-24-006852
us-gaap IncreaseDecreaseInDeferredRevenue Increase (Decrease) in Deferred Revenue USD -3.21M 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-05 0001628280-25-049694
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -7.08M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070273
us-gaap IncreaseDecreaseInOtherOperatingAssets Increase (Decrease) in Other Operating Assets USD -1.29M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070273
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 2.84M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070273
us-gaap IncrementalCommonSharesAttributableToContingentlyIssuableShares Incremental Common Shares Attributable to Dilutive Effect of Contingently Issuable Shares shares 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-26 0001628280-24-006852
us-gaap IncrementalCommonSharesAttributableToShareBasedPaymentArrangements Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements shares 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-27 0001628280-25-008245
us-gaap IntangibleAssetsNetExcludingGoodwill Intangible Assets, Net (Excluding Goodwill) USD 7.63M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070273
us-gaap InterestReceivable Interest Receivable USD 4.00M 2023-12-31 2023 FY 10-K 2024-02-26 0001628280-24-006852
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 25.48M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070273
us-gaap InvestmentIncomeNetAmortizationOfDiscountAndPremium Investment Income, Net, Amortization of Discount and Premium USD 40.13M 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-01 0001628280-24-034195
us-gaap LeaseCost Lease, Cost USD 18.45M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-23 0001628280-26-010749
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 121.40M 2025-12-31 2025 FY 10-K 2026-02-23 0001628280-26-010749
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 49.32M 2025-12-31 2025 FY 10-K 2026-02-23 0001628280-26-010749
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 13.79M 2025-12-31 2025 FY 10-K 2026-02-23 0001628280-26-010749
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 15.07M 2025-12-31 2025 FY 10-K 2026-02-23 0001628280-26-010749
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 14.70M 2025-12-31 2025 FY 10-K 2026-02-23 0001628280-26-010749
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 14.43M 2025-12-31 2025 FY 10-K 2026-02-23 0001628280-26-010749
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 14.08M 2025-12-31 2025 FY 10-K 2026-02-23 0001628280-26-010749
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 4.85M 2022-09-30 2022 Q3 10-Q 2022-11-03 0000950170-22-021854
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 23.55M 2025-12-31 2025 FY 10-K 2026-02-23 0001628280-26-010749
us-gaap Liabilities Liabilities USD 215.82M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070273
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 1.11B 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070273
us-gaap LiabilitiesCurrent Liabilities, Current USD 80.66M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070273
us-gaap LongTermInvestments Long-term Investments USD 442.93M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070273
us-gaap MarketableSecuritiesCurrent Marketable Securities, Current USD 235.77M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070273
us-gaap MinorityInterest Stockholders' Equity Attributable to Noncontrolling Interest USD 44,000 2023-03-31 2023 Q1 10-Q 2023-05-08 0000950170-23-018789
us-gaap MinorityInterestDecreaseFromRedemptions Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests USD 100,000 2023-01-01 2023-12-31 2025 FY 10-K 2026-02-23 0001628280-26-010749
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 242.53M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070273
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -140.75M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070273
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -115.14M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070273
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -141.87M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070273
us-gaap NetIncomeLossAttributableToNoncontrollingInterest Net Income (Loss) Attributable to Noncontrolling Interest USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-23 0001628280-26-010749
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -65.28M 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-03 0001628280-24-020299
us-gaap NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1 Noncash or Part Noncash Acquisition, Value of Assets Acquired USD 593,000 2018-01-01 2018-12-31 2020 FY 10-K 2021-02-25 0001564590-21-008915
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 21.82M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070273
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-26 0001628280-24-006852
us-gaap NumberOfReportableSegments Number of Reportable Segments segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070273
us-gaap OperatingExpenses Operating Expenses USD 433.67M 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-04 0000950170-21-003057
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -163.48M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070273
us-gaap OperatingLeaseCost Operating Lease, Cost USD 10.44M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-23 0001628280-26-010749
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 97.85M 2025-12-31 2025 FY 10-K 2026-02-23 0001628280-26-010749
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 9.32M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070273
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 81.46M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070273
us-gaap OperatingLeasePayments Operating Lease, Payments USD 13.60M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-23 0001628280-26-010749
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 57.99M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070273
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.054 2025-12-31 2025 FY 10-K 2026-02-23 0001628280-26-010749
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 6.46M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070273
us-gaap OtherAssets Other Assets USD 23.41M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070273
us-gaap OtherAssetsCurrent Other Assets, Current USD 100,000 2024-12-31 2024 FY 10-K 2025-02-27 0001628280-25-008245
us-gaap OtherComprehensiveIncomeLossNetOfTax Other Comprehensive Income (Loss), Net of Tax USD -340,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-23 0001628280-26-010749
us-gaap OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent USD -4.84M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070273
us-gaap OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax USD 736,000 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-26 0001564590-20-013194
us-gaap OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, after Tax USD -106,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070273
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax USD -4.95M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070273
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 20.72M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070273
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD -1.36M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070273
us-gaap OtherOperatingActivitiesCashFlowStatement Other Operating Activities, Cash Flow Statement USD 59,000 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-06 0001628280-25-038431
us-gaap PaymentsForProceedsFromOtherInvestingActivities Payments for (Proceeds from) Other Investing Activities USD 412,000 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-04 0001628280-24-044995
us-gaap PaymentsForRestructuring Payments for Restructuring USD 13.66M 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-23 0001628280-26-010749
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 3.69M 2019-01-01 2019-09-30 2020 Q3 10-Q 2020-11-10 0001564590-20-052966
us-gaap PaymentsToAcquireAssetsInvestingActivities Payments to Acquire Assets, Investing Activities USD 1.74M 2018-01-01 2018-12-31 2020 FY 10-K 2021-02-25 0001564590-21-008915
us-gaap PaymentsToAcquireBusinessesNetOfCashAcquired Payments to Acquire Businesses, Net of Cash Acquired USD 27.25M 2017-01-01 2017-12-31 2019 FY 10-K 2020-03-26 0001564590-20-013194
us-gaap PaymentsToAcquireInvestments Payments to Acquire Investments USD 638.96M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070273
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 456,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070273
us-gaap PaymentsToAcquireShortTermInvestments Payments to Acquire Short-term Investments USD 495.93M 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-19 0001564590-19-043877
us-gaap PaymentsToMinorityShareholders Payments to Noncontrolling Interests USD 0 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-04 0001628280-24-044995
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070273
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 10.00M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070273
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070273
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070273
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070273
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 47.98M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070273
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 126.40M 2019-10-09 2019-10-10 2021 FY 10-K 2022-02-28 0000950170-22-002295
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 162.35M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-07 0001628280-26-031471
us-gaap ProceedsFromIssuanceOfConvertiblePreferredStock Proceeds from Issuance of Convertible Preferred Stock USD 317.33M 2019-01-01 2019-12-31 2021 FY 10-K 2022-02-28 0000950170-22-002295
us-gaap ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments Proceeds from Maturities, Prepayments and Calls of Short-term Investments USD 320.93M 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-19 0001564590-19-043877
us-gaap ProceedsFromMinorityShareholders Proceeds from Noncontrolling Interests USD 0 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-04 0001628280-24-044995
us-gaap ProceedsFromPaymentsForOtherFinancingActivities Proceeds from (Payments for) Other Financing Activities USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070273
us-gaap ProceedsFromSaleMaturityAndCollectionsOfInvestments Proceeds from Sale, Maturity and Collection of Investments USD 498.67M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070273
us-gaap ProceedsFromSaleOfMachineryAndEquipment Proceeds from Sale of Machinery and Equipment USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070273
us-gaap ProceedsFromSaleOfPropertyHeldForSale Proceeds from Sale of Property Held-for-sale USD 180,000 2020-01-01 2020-09-30 2021 Q3 10-Q 2021-11-04 0000950170-21-003057
us-gaap ProceedsFromSaleOfPropertyPlantAndEquipment Proceeds from Sale of Property, Plant, and Equipment USD 3.37M 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-27 0001628280-25-008245
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 3.25M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070273
us-gaap ProceedsFromStockPlans Proceeds from Stock Plans USD 1.36M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070273
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -437.99M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-23 0001628280-26-010749
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 103.09M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070273
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 47.77M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070273
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 324.25M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070273
us-gaap ResearchAndDevelopmentInProcess Research and Development in Process USD 75.68M 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-28 0000950170-23-005118
us-gaap RestrictedCashAndCashEquivalents Restricted Cash and Cash Equivalents USD 8.80M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070273
us-gaap RestrictedCashAndCashEquivalentsAtCarryingValue Restricted Cash and Cash Equivalents, Current USD 1.93M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070273
us-gaap RestrictedCashAndCashEquivalentsNoncurrent Restricted Cash and Cash Equivalents, Noncurrent USD 6.92M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070273
us-gaap RestructuringAndRelatedCostExpectedCostRemaining1 Restructuring and Related Cost, Expected Cost Remaining USD 2.00M 2024-06-30 2024 Q2 10-Q 2024-08-01 0001628280-24-034195
us-gaap RestructuringAndRelatedCostNumberOfPositionsEliminated Restructuring and Related Cost, Number of Positions Eliminated position 75 2023-12-01 2023-12-31 2024 Q2 10-Q 2024-08-01 0001628280-24-034195
us-gaap RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent Restructuring and Related Cost, Number of Positions Eliminated, Period Percent pure 0.12 2023-12-01 2023-12-31 2024 Q2 10-Q 2024-08-01 0001628280-24-034195
us-gaap RestructuringCharges Restructuring Charges USD 34.99M 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-23 0001628280-26-010749
us-gaap RestructuringCostsAndAssetImpairmentCharges Restructuring Costs and Asset Impairment Charges USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070273
us-gaap RestructuringReserve Restructuring Reserve USD 4.50M 2023-12-31 2024 Q1 10-Q 2024-05-03 0001628280-24-020299
us-gaap RestructuringReserveCurrent Restructuring Reserve, Current USD 1.61M 2024-12-31 2025 FY 10-K 2026-02-23 0001628280-26-010749
us-gaap RestructuringReserveSettledWithoutCash2 Restructuring Reserve, Settled without Cash USD 2.33M 2024-07-01 2024-09-30 2024 Q3 10-Q 2024-11-04 0001628280-24-044995
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -1.34B 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070273
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 68.56M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-23 0001628280-26-010749
us-gaap Revenues Revenues USD 238.73M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070273
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070273
us-gaap SaleLeasebackTransactionNetProceedsFinancingActivities Sale Leaseback Transaction, Net Proceeds, Financing Activities USD 1.20M 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-19 0001564590-19-043877
us-gaap SellingGeneralAndAdministrativeExpense Selling, General and Administrative Expense USD 77.97M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070273
us-gaap SeveranceCosts1 Severance Costs USD 5.90M 2023-01-01 2023-12-31 2024 Q1 10-Q 2024-05-03 0001628280-24-020299
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 34.93M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070273
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070273
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0.933 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-07 0001628280-26-031471
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum pure 0.933 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070273
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum pure 0.813 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070273
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.043 2024-01-01 2024-03-31 2025 Q1 10-Q 2025-05-08 0001628280-25-023291
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum pure 0.049 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070273
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum pure 0.038 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070273
us-gaap ShortTermLeaseCost Short-term Lease, Cost USD 239,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-28 0000950170-23-005118
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 896.04M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070273
us-gaap StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD 896.04M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070273
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 0.222 2019-09-16 2022 FY 10-K 2023-02-28 0000950170-23-005118
us-gaap StockIssued1 Stock Issued USD 2.48M 2017-01-01 2017-12-31 2019 FY 10-K 2020-03-26 0001564590-20-013194
us-gaap StockIssuedDuringPeriodValueAcquisitions Stock Issued During Period, Value, Acquisitions USD 2.48M 2017-01-01 2017-12-31 2019 FY 10-K 2020-03-26 0001564590-20-013194
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 636.61M 2019-01-01 2019-12-31 2021 FY 10-K 2022-02-28 0000950170-22-002295
us-gaap StockIssuedDuringPeriodValueEmployeeStockPurchasePlan Stock Issued During Period, Value, Employee Stock Purchase Plan USD 1.36M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070273
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 162.35M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-07 0001628280-26-031471
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardGross Stock Issued During Period, Value, Restricted Stock Award, Gross USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070273
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 3.25M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070273
us-gaap TemporaryEquityCarryingAmountAttributableToParent Temporary Equity, Carrying Amount, Attributable to Parent USD 309.14M 2018-12-31 2019 FY 10-K 2020-03-26 0001564590-20-013194
us-gaap TemporaryEquityLiquidationPreference Temporary Equity, Liquidation Preference USD 0 2019-12-31 2019 FY 10-K 2020-03-26 0001564590-20-013194
us-gaap TemporaryEquityParOrStatedValuePerShare Temporary Equity, Par or Stated Value Per Share USD/shares 0 2019-12-31 2019 FY 10-K 2020-03-26 0001564590-20-013194
us-gaap TemporaryEquitySharesAuthorized Temporary Equity, Shares Authorized shares 0 2019-12-31 2019 FY 10-K 2020-03-26 0001564590-20-013194
us-gaap TemporaryEquitySharesIssued Temporary Equity, Shares Issued shares 0 2019-12-31 2019 FY 10-K 2020-03-26 0001564590-20-013194
us-gaap TemporaryEquitySharesOutstanding Temporary Equity, Shares Outstanding shares 0 2019-12-31 2019 FY 10-K 2020-03-26 0001564590-20-013194
us-gaap TenantImprovements Tenant Improvements USD 10.50M 2020-12-31 2020 FY 10-K 2021-02-25 0001564590-21-008915
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 19.00M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070273
us-gaap UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions USD 2.22M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-23 0001628280-26-010749
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued USD 0 2022-12-31 2022 FY 10-K 2023-02-28 0000950170-23-005118
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense USD 1.30M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-23 0001628280-26-010749
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions USD 1.61M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-23 0001628280-26-010749
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-23 0001628280-26-010749
us-gaap UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate Unrecognized Tax Benefits that Would Impact Effective Tax Rate USD 0 2021-12-31 2021 FY 10-K 2022-02-28 0000950170-22-002295
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 73.70M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-23 0001628280-26-010749
us-gaap VariableLeaseCost Variable Lease, Cost USD 8.01M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-23 0001628280-26-010749
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 161.56M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070273
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 127.74M 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-06 0001564590-21-024948
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 161.56M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070273

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →